Tuesday, Jun 25 2019 | Time 01:34 Hrs(IST)
image
  • Whoring racket busted in MP capital
  • Milan to learn from Beijing in hosting Winter Olympics, says mayor
  • Monsoon breaks over MP
  • Amit Shah, Rajnath & other BJP leaders pay tribute to Madan Lal Saini
  • CM Pema Khandu felicitates members of girls' football team
  • NABARD regional office GM calls on Pema Khandu
  • Arunachal govt invites suggestions for upcoming ‘State Budget’
  • MP CM sets month’s deadline for remission
  • UN concerned over Yemen escalation after latest attack on Saudi airport – Spokesman
  • Rapinoe's penalty brace help US knock out Spain for World Cup quarters
  • Rapinoe's penalty brace help US knock out Spain for World Cup quarters
  • Rapinoe's penalty brace help US knock out Spain for World Cup quarters
  • US imposes new, "hard-hitting" sanctions on Iran amid tensions
Business Economy


Morepen Lab’s net profit rises by 179 pc

New Delhi, May 1 (UNI) Morepen Laboratories Limited has reported a 179 per cent rise in its net profit at Rs 7.73-crore and 17.4 per cent rise in its net sales revenue at Rs 141-crore in the fourth quarter (Q4) of fiscal 2016-17.

The net profit and the net sales revenue stood at Rs 2.77-crore and Rs 119.77-crore in the corresponding quarter of the fiscal 2015-16.

Announcing the results, Sushil Suri, Chairman and Managing Director, Morepen Laboratories, said that the company’s expanding global reach assisted in achieving a higher topline in Q4 FY 2016-17. Export sales registered a growth of 29 per cent in Q4 at Rs 73-crore. Sales from domestic operations, however, registered a marginal growth of 7 per cent at Rs 68-crore.

“The bulk drugs (API) segment continued to excel in the quarter by contributing 67 per cent to the company’s total turnover. Morepen Lab’s blockbuster bulk drug Loratadine has once again emerged as a growth accelerator for the company in Q4 FY 2016-17,” he said.

According to Mr Suri, Sales from Loratadine alone increased by 54 per cent in Q4 at Rs 34.35-crore. Total bulk drugs sales in Q4 increased by 21 per cent at Rs 94.35-crore.

OTC (Over the Counter) products and Formulations also recorded good sales numbers for the quarter under consideration. Total sales from OTC products, comprising Burnol & Lemolate, went up by 11 per cent in Q4 FY 2016-17.

“Consistent focus on backward integration, research and process innovation has helped company garner better foothold in the market and company’s vision to invest in the new markets is showing results on the expected lines,” he said.

During the entire financial year 2016-17, Morepen Lab’s net profit grew by 46 per cent at Rs 23.04-crore as against Rs 15.78-crore net profit registered in the previous fiscal. Net sales revenue in FY 2016-17 grew by 21 per cent at Rs 529.18-crore.

The total API business registered a growth of 23 per cent at Rs 340.13-crore, Dr. Morepen Home Diagnostics business registered a growth of 23 per cent at Rs 77.76-crore, formulations business registered a growth of 10 per cent at Rs 26.59-crore and Product Contract Manufacturing and Brand Sharing business grew by 16 per cent at Rs 84.69-crore.
UNI ADP RSA SNU 1539
More News
India focusing on unconventional life goals, says survey

India focusing on unconventional life goals, says survey

24 Jun 2019 | 7:30 PM

New Delhi, Jun 24 (UNI) India is focusing on unconventional life goals, entrepreneurship, health and fitness and travel, a study said here on Monday.

see more..
Garmin India launches multisport watch at Rs 59,990

Garmin India launches multisport watch at Rs 59,990

24 Jun 2019 | 7:30 PM

New Delhi, Jun 24 (UNI) Garmin India on Monday launched an all new premium GPS Running Smartwatch- Forerunner 945 at a price of Rs 59,990 to cater to the needs of the advanced runners and sports enthusiasts.

see more..
NITI Aayog to release 2nd edition of Healthy States, Progressive India report

NITI Aayog to release 2nd edition of Healthy States, Progressive India report

24 Jun 2019 | 7:28 PM

New Delhi, Jun 24 (UNI) NITI Aayog will release the second edition of “Healthy States, Progressive India” report on Jun 25.

see more..
Honor 20 offers 90 pc buy back guarantee in 90 days

Honor 20 offers 90 pc buy back guarantee in 90 days

24 Jun 2019 | 7:26 PM

New Delhi, Jun 24 (UNI) Smartphone Honor on Monday came up with first of its kind challenge, where it will offer up to 90 per cent buy back guarantee in 90 days on HONOR 20.

see more..

UAE's LuLu Group to explore investment opportunities in HP

24 Jun 2019 | 6:48 PM

Shimla, Jun 24 (UNI) Accepting Himachal Pradesh Chief Minister Jai Ram Thakur's invitation to explore investment opportunities in the state, United Arab Emirates based LuLu Group International has decided to send a team to traverse the areas of collaboration.

see more..
image